Dongfang Wealth Securities released a research report on April 16 stating that it gave Kaisei Healthcare (300633.SZ) a purchase rating. The main reasons for the rating include: 1) the ultrasound business is growing steadily, and the endoscopy business maintains a high growth rate; 2) strengthening R&D investment in high-end products to enhance product strength; 3) speeding up the overseas localization layout, and overseas revenue growth is impressive; 4) the cost level is relatively stable, and profitability is rising steadily. (Mainichi Keizai Shimbun)
东方财富证券4月16日发布研报称，给予开立医疗（300633.SZ）买入评级。评级理由主要包括：1）超声业务平稳增长，内镜业务维持高增速；2）强化高端产品的研发投入，提升产品力；3）加速海外本地化布局，海外收入增势亮眼；4）费用水平相对稳定，盈利能力稳中有升。（每日经济新闻）
Dongfang Wealth Securities released a research report on April 16 stating that it gave Kaisei Healthcare (300633.SZ) a purchase rating. The main reasons for the rating include: 1) the ultrasound business is growing steadily, and the endoscopy business mai
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.